VOCSN the Flagship Product of Vincent Medical’s Partner
Named “Best New Therapeutic Technology Solution”
At MedTech Breakthrough 2017 Awards
* * *
Affirms Vincent Medical’s Business Strategies
Supportive of Product Innovation for Fueling Future Growth
Vincent Medical Holdings Limited (“Vincent Medical” or together with its subsidiaries, the “Group”, stock code: 1612), the second largest exporter of respiratory and anaesthesia disposables in the PRC and a Hong Kong-headquartered medical device group, announced that “VOCSN”, the revolutionary life-support ventilator and flagship product of Ventec Life Systems, Inc. (“Ventec”), was named “Best New Therapeutic Technology Solution” at the MedTech Breakthrough 2017 Awards (the “Awards”).
Confident of the market potential of “VOCSN”, the Group signed an exclusive manufacturing and distribution agreement with Ventec last August, adding it to the Group’s spectrum of proven respiratory products. This latest recognition evidenced the effectiveness of Vincent Medical’s business strategies supportive of product innovation and expansion of product offerings.
“VOCSN” received FDA clearance in April 2017 and now, two months later and to the encouragement of Vincent Medical, is recognised as the Best New Therapeutic Technology Solution in the Medical Device category of MedTech Breakthrough 2017 Awards. The Awards honours top companies, people, platforms and products in the health, fitness and medical technology industries and comes with different award categories such as Medical Device, Medical Data, Genomincs and Patient Engagement.
Mr. Vincent Choi, Founder, Chairman and Executive Director of Vincent Medical, said, “We see tremendous value in starting early our pursuit of new products and technologies with high commercial potential hence promise to bring us long term value. The Group will continue to explore collaboration and investment opportunities that can fuel its growth momentum in the future.”